Protracted Low-Dose Effects on Human Endothelial Cell Proliferation and Survival in Vitro Reveal a Selective Antiangiogenic Window for Various Chemotherapeutic Drugs1
Cancer Res (2002) 62 (23): 6938–6943.
Currently there are no citedby results. Try again later.
